Literature DB >> 27443594

Meningococcal pneumonia.

Matthias Vossen1, Dieter Mitteregger2, Christoph Steininger3.   

Abstract

Neisseria meningitidis remains the most important cause of bacterial meningitis worldwide, particularly in children and young adults. The second most common and a potentially severe end-organ manifestation of invasive meningococcal disease (excluding systemic sepsis) is meningococcal pneumonia. It occurs in between 5% and 15% of all patients with invasive meningococcal disease and is thus the second most common non-systemic end-organ manifestation. To establish the diagnosis requires a high level of clinical awareness - the incidence is therefore very likely underreported and underestimated. This review of 344 meningococcal pneumonia cases reported in the Americas, Europe, Australia, and Asia between 1906 and 2015 presents risk factors, pathogenesis, clinical manifestations, diagnostic approaches, treatment, and prognosis of meningococcal pneumonia.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Invasive meningococcal disease; Neisseria meningitidis; Pneumonia

Mesh:

Year:  2016        PMID: 27443594     DOI: 10.1016/j.vaccine.2016.07.013

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  A Double Whammy Pneumonia: The First Reported Case of Concurrent Neisseria meningitidis and SARS-CoV-2 Pneumonia.

Authors:  Michael Valdez; Rupam Sharma; Jaspreet Joshi; Harleen Sandhu; Shikha Mishra; Rasha Kuran; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

2.  Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012.

Authors:  O Säll; B Stenmark; M Glimåker; S Jacobsson; P Mölling; P Olcén; H Fredlund
Journal:  Epidemiol Infect       Date:  2017-05-08       Impact factor: 2.451

Review 3.  Meningococcal pneumonia: a review.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Pneumonia (Nathan)       Date:  2019-08-25

4.  Complete genome and methylome analysis of Neisseria meningitidis associated with increased serogroup Y disease.

Authors:  Bianca Stenmark; Odile B Harrison; Lorraine Eriksson; Brian P Anton; Alexey Fomenkov; Richard J Roberts; Ave Tooming-Klunderud; Holly B Bratcher; James E Bray; Sara Thulin-Hedberg; Martin C J Maiden; Paula Mölling
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

5.  Occurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghana.

Authors:  Augustina K Arjarquah; Evangeline Obodai; Hannah Ayettey Anie; Michael Aning Osei; John Kofi Odoom; Joseph H K Bonney; Eric Behene; Erasmus N Kotey; James Aboagye; Stephen O Nyarko; Jeannette Bentum; Clara Yeboah; Selassie Kumordjie; Bright Agbodzi; Keren Attiku; Gifty Mawuli; Andrew Letizia; William K Ampofo; Osbourne Quaye
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

6.  Does Dexamethasone Helps in Meningococcal Sepsis?

Authors:  Ilir Tolaj; Hamdi Ramadani; Murat Mehmeti; Hatixhe Gashi; Arbana Kasumi; Visar Gashi; Haki Jashari
Journal:  Med Arch       Date:  2017-06

7.  Invasive meningococcal disease without meningitis: a forgotten diagnosis.

Authors:  Saqib Walayat; Nooreen Hussain; Abdullah H Malik; Elsa Vazquez-Melendez; Bhagat S Aulakh; Teresa Lynch
Journal:  Int Med Case Rep J       Date:  2018-04-12

8.  Meningococcal Pneumonia in a Young Healthy Male.

Authors:  Abdullah M Al Alawi
Journal:  Case Rep Infect Dis       Date:  2018-08-27

9.  Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017.

Authors:  Eva L Sudbury; Siobhan O'Sullivan; David Lister; Deepa Varghese; Keshan Satharasinghe
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

10.  Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and 'Dark Energy': loss of biorhythms (Anabolism v. Catabolism).

Authors:  Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.